Advertisement
News
Advertisement

Ocular Therapeutix enrolls patients in Phase 3 trial

Tue, 09/04/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Ocular Therapeutix Inc. of Bedford has completed enrollment of a Phase 3 clinical trial of its ReSure Sealant, a polyethylene glycol (PEG)-based hydrogel intended for use during cataract surgery, according to a statement from the company.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading